Floatz logo

Hcq

Ovarian Hyperstimulation Syndrome

Aljazeera HospitalUNKNOWNN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Ovarian Hyperstimulation Syndrome cohort.

Asset / SponsorPhaseRating
Human Chorionic Gonadotropin
UConn Health
Phase 4BB
Ganirelix
Eugonia
Phase 4BB
Cabergoline
Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
N/AD
Degarelix
Bioroma
UnknownD

Same molecule, other indications

Hcq is also rated in:

breast cancerActive
CC
Indicative · Phase 2
46 / 100
View asset →
hepatocellular carcinomaDormant
CC
Indicative · Phase 1/2
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →